title: Thrombotic microangiopathy and anti-VEGF agents.
authors.forename: Hassane
authors.initials: H
authors.lastname: Izzedine
authors.forename: Isabelle
authors.initials: I
authors.lastname: Brocheriou
authors.forename: Gilbert
authors.initials: G
authors.lastname: Deray
authors.forename: Olivier
authors.initials: O
authors.lastname: Rixe
mesh_terms: D001706:Biopsy; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000077146:Irinotecan; D007678:Kidney Glomerulus / Q000098:blood supply / Q000473:pathology; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy; D040262:Receptors, Vascular Endothelial Growth Factor / Q000502:physiology; D011993:Recombinant Fusion Proteins / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D013927:Thrombosis / Q000139:chemically induced* / Q000175:diagnosis*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors* / Q000502:physiology
chemical_list: D011993:Recombinant Fusion Proteins; D042461:Vascular Endothelial Growth Factor A; D000077146:Irinotecan; D040262:Receptors, Vascular Endothelial Growth Factor; D002166:Camptothecin